Skip to content

Cost-effectiveness and cost-utility of at-home infrared temperature monitoring in reducing the incidence of foot ulcer recurrence in patients with diabetes.

Cost-effectiveness and cost-utility of at-home infrared temperature monitoring in reducing the incidence of foot ulcer recurrence in patients with diabetes. - DIATEMP

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON44744
Enrollment
304
Registered
2015-06-17
Start date
2015-11-05
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic foot diabetic neuropathy

Interventions

the intervention is usual care added with at-home daily measurement of foot temperatures at 6 predefined locations on both feet. If foot temperature is increased on 2 consecutive days, the patient i

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Diabetes mellitus; 2. Age 18 or above; 3. Peripheral neuropathy; 4. Recent history of a foot ulcer or foot amputation, i.e. an ulcer has been present for at least 2 weeks and has healed within four years before randomization, or a diagnosis of midfoot or forefoot Charcot neuro-osteoarthropathy; 5. Ability to provide informed consent; 6. Ambulatory status (i.e. not permanently wheel-chair bound). 7. The patient is treated by a podiatrist or is willing to undergo treatment by a podiatrist from the study.

Exclusion criteria

Exclusion criteria: 1. Active foot ulceration or open amputation sites. 2. Active Charcot neuro-osteo arthropathy. 3. Active foot infection, based on criteria of the PEDIS classification. 4. Amputation proximal to the Chopart joint in both feet. 5. Severe illness that would make 18-months survival unlikely, based on the clinical judgment by the physician 6. Concomitant severe physical or mental conditions that limit the ability to follow instructions for the study, based on the clinical judgment by the physician. This includes the inability to perform temperature measurements, without having a caretaker who can perform the temperature measurements. 7. Current use of home-monitoring of foot temperature. 8. Critical limb ischemia, based on criteria of the PEDIS classification

Design outcomes

Primary

MeasureTime frame
- Costs per patient without a foot ulcer and per quality adjusted life year. - The proportion of patients with a foot ulcer recurrence during 18-month follow-up.

Secondary

MeasureTime frame
- Costs of advanced therapy and ulcer treatment. - Adherence to at-home foot temperature monitoring. - Health-related quality of life.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)